Kaplan Brett 4
4 · Climb Bio, Inc. · Filed Jan 15, 2025
Insider Transaction Report
Form 4
Climb Bio, Inc.CLYM
Kaplan Brett
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-13+500,000→ 500,000 totalExercise: $1.92Exp: 2035-01-12→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 13, 2025 (the "Grant Date"). The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the Grant Date and the remainder are scheduled to vest in 36 equal monthly installments through January 13, 2029, subject to the Reporting Person's continued service.